Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Antonio
Institutions:
Northwestern University,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Observed institutions:
Northwestern University,
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
ORCID:
0009-0001-6242-5392
Observed ORCID:
0009-0001-6242-5392
OpenAlex ID:
A5080838215
Impact of sequencing of CART vs bi-specific antibody on survival in relapsed/refractory large B-cell lymphoma: An analysis from the ABC consortium
2025
·
Max Kelsten
, Colin Thomas
, et al.
·
Blood
·
3
PDF
Enhancing catchment area tools: A de-identification method for integrating clinical trial data with Cancer InFocus
2024
·
Daniel Antonio
, Todd Burus
, et al.
·
Preventive Oncology & Epidemiology
·
1
Disparities in palliative care and advance care planning by race/ethnicity and language preference in patients with advanced GI cancer.
2026
·
Constanza Menendez Alurralde
, Collin Hanson
, et al.
·
JCO Oncology Practice
PDF
Time to treatment initiation among patients with colorectal cancer and limited English proficiency.
2026
·
Sarah Marie Marini
, Daniel Antonio
, et al.
·
JCO Oncology Practice
PDF
Impact of a community-centered intervention on knowledge, confidence, and attitudes toward clinical trials: A pilot survey study
2026
·
Oriana Krivenko
, Nicole Diaz
, et al.
·
Gynecologic Oncology
Real-world outcomes with bispecific antibody therapies for aggressive B-cell lymphomas in octogenarians
2025
·
Lindsey Fitzgerald
, Elena Nazarenko
, et al.
·
Blood
PDF
Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium
2025
·
Victoria Gill
, Ari Pelcovits
, et al.
·
Blood
PDF
Outcomes of patients with Relapsed/Refractory aggressive B-cell lymphoma receiving bispecific antibody therapy as monotherapy or in combination with targeted therapy
2025
·
Timothy Oh
, Ari Pelcovits
, et al.
·
Blood
Socioeconomic disadvantage, as measured by area deprivation index (ADI), impacts survival in patients with relapsed/refractory aggressive lymphoma treated with CART
2025
·
Daniel Antonio
, Tarneka Manning
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
9
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type